marketcaparena
Search

    RCUS

    Arcus Biosciences, Inc.

    Company overview

    Market capitalization
    $3.18B
    Employees
    601
    Latest publication
    2026-09-29
    About Arcus Biosciences, Inc.

    Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. The company's development product portfolio includes Casdatifan, a HIF-2a inhibitor for the treatment of kidney cancer; Domvanalimab, an anti-TIGIT antibody, which is in Phase 2 and Phase 3 clinical trial for lung and gastrointestinal cancers; and Zimberelimab, an anti-PD-1 antibody. It also develops Quemliclustat, a small molecule inhibitor that targets the CD73 enzyme in the ATP-adenosine pathway, which is in phase 3 and phase 1/1b clinical trial for lung and pancreatic cancer. In addition, the company develops AB598, a CD39 antibody, which is in phase 1/1b clinical study for gastrointestinal cancer and AB801, an AXL inhibitor, which is in Phase 1b clinical trial for lung cancer. It has clinical collaboration with AstraZeneca for the Phase 3 PACIFIC-8 trial evaluating domvanalimab and durvalumab in Stage 3 NSCLC and for a Phase 1/1b study evaluating casdatifan and volrustomig in IO-naive patients with ccRCC; BVF Partners L.P. to support the discovery and development of compounds for the treatment of inflammatory diseases; and Bristol-Myers Squibb Company to develop a novel treatment regimen that delivers tumor control in kidney cancer. Arcus Biosciences, Inc. was incorporated in 2015 and is based in Hayward, California.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USDQ1 20242024-03-31 · USDQ4 20232023-12-31 · USDQ3 20232023-09-30 · USD
    Total Revenue160,000,000USD28,000,000USD26,000,000USD48,000,000USD39,000,000USD145,000,000USD31,000,000USD32,000,000USD
    Cost Of Revenue2,000,000USD—3,000,000USD—2,000,000USD3,000,000USD5,000,000USD3,000,000USD
    Gross Profit160,000,000USD28,000,000USD26,000,000USD48,000,000USD39,000,000USD145,000,000USD31,000,000USD32,000,000USD
    Research Development139,000,000USD122,000,000USD101,000,000USD123,000,000USD115,000,000USD109,000,000USD93,000,000USD82,000,000USD
    Selling General Administrative29,000,000USD28,000,000USD28,000,000USD30,000,000USD30,000,000USD32,000,000USD29,000,000USD30,000,000USD
    Total Operating Expenses168,000,000USD150,000,000USD129,000,000USD153,000,000USD145,000,000USD161,000,000USD122,000,000USD112,000,000USD
    Operating Income-8,000,000USD-122,000,000USD-103,000,000USD-105,000,000USD-106,000,000USD-16,000,000USD-91,000,000USD-80,000,000USD
    Interest Income10,000,000USD11,000,000USD12,000,000USD14,000,000USD13,000,000USD13,000,000USD11,000,000USD12,000,000USD
    Interest Expense2,000,000USD1,000,000USD2,000,000USD1,000,000USD0USD1,000,000USD2,000,000USD1,000,000USD
    Net Interest Income8,000,000USD10,000,000USD10,000,000USD13,000,000USD13,000,000USD12,000,000USD11,000,000USD11,000,000USD
    Income Before Tax-8,000,000USD-112,000,000USD-94,000,000USD-92,000,000USD-93,000,000USD-4,000,000USD-80,000,000USD-69,000,000USD
    Tax Provision0USD0USD1,000,000USD0USD0USD0USD1,000,000USD2,000,000USD
    Net Income-8,000,000USD-112,000,000USD-94,000,000USD-92,000,000USD-93,000,000USD-4,000,000USD-81,000,000USD-71,000,000USD
    Net Income From Continuing Ops0USD-112,000,000USD-95,000,000USD-92,000,000USD-93,000,000USD-4,000,000USD-81,000,000USD-71,000,000USD
    Ebit2,000,000USD-111,000,000USD-92,000,000USD-91,000,000USD-93,000,000USD4,000,000USD-80,000,000USD-68,000,000USD
    Ebitda4,000,000USD-108,000,000USD-89,000,000USD-89,000,000USD-91,000,000USD7,000,000USD-77,000,000USD-67,000,000USD
    Depreciation And Amortization2,000,000USD3,000,000USD3,000,000USD2,000,000USD2,000,000USD3,000,000USD3,000,000USD1,000,000USD
    Reconciled Depreciation2,000,000USD3,000,000USD3,000,000USD2,000,000USD2,000,000USD3,000,000USD3,000,000USD1,000,000USD
    Total Other Income Expense Net8,000,000USD10,000,000USD9,000,000USD13,000,000USD13,000,000USD12,000,000USD11,000,000USD11,000,000USD
    Income Tax Expense——1,000,000USD——1,000,000USD1,000,000USD2,000,000USD
    Unclassified Operating Expenses—————20,000,000USD——
    Net Income Applicable To Common Shares———————-71,000,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20192019-12-31 · USDFY 20172017-12-31 · USDFY 20162016-12-31 · USD
    Total Revenue258,000,000USD117,000,000USD112,000,000USD383,000,000USD15,000,000USD1,413,000USD0USD
    Cost Of Revenue10,000,000USD340,000,000USD14,000,000USD7,057,000USD78,481,000USD2,612,000USD1,314,000USD
    Gross Profit258,000,000USD117,000,000USD112,000,000USD383,000,000USD15,000,000USD1,413,000USD-1,314,000USD
    Research Development448,000,000USD340,000,000USD288,000,000USD257,000,000USD78,481,000USD47,218,000USD14,247,000USD
    Selling General Administrative120,000,000USD117,000,000USD104,000,000USD72,000,000USD25,228,000USD7,636,000USD3,935,000USD
    Unclassified Operating Expenses20,000,000USD——————
    Total Operating Expenses588,000,000USD457,000,000USD392,000,000USD329,000,000USD103,709,000USD54,854,000USD18,182,000USD
    Operating Income-330,000,000USD-340,000,000USD-280,000,000USD54,000,000USD-88,709,000USD-53,441,000USD-18,182,000USD
    Interest Income52,000,000USD41,000,000USD16,000,000USD657,000USD5,201,000USD359,000USD212,000USD
    Interest Expense4,000,000USD2,000,000USD2,000,000USD260,000USD0USD0USD0USD
    Net Interest Income48,000,000USD39,000,000USD14,000,000USD397,000USD5,201,000USD359,000USD212,000USD
    Income Before Tax-283,000,000USD-301,000,000USD-266,000,000USD55,000,000USD-84,710,000USD-53,082,000USD-17,970,000USD
    Income Tax Expense1,000,000USD6,000,000USD1,000,000USD2,000,000USD-8,779,000USD0USD0USD
    Tax Provision1,000,000USD6,000,000USD1,000,000USD1,815,000USD———
    Net Income-283,000,000USD-307,000,000USD-267,000,000USD53,000,000USD-75,931,000USD-53,082,000USD-17,970,000USD
    Net Income From Continuing Ops-284,000,000USD-307,000,000USD-267,000,000USD52,830,000USD-84,710,000USD-53,082,000USD-17,970,000USD
    Ebit-279,000,000USD-299,000,000USD-264,000,000USD55,000,000USD-88,709,000USD-53,441,000USD-18,182,000USD
    Ebitda-269,000,000USD-291,000,000USD-258,000,000USD59,000,000USD-85,131,000USD-50,829,000USD-16,868,000USD
    Depreciation And Amortization10,000,000USD8,000,000USD6,000,000USD4,000,000USD3,578,000USD2,612,000USD1,314,000USD
    Reconciled Depreciation10,000,000USD8,000,000USD6,000,000USD3,843,000USD3,578,000USD2,612,000USD—
    Total Other Income Expense Net47,000,000USD39,000,000USD14,000,000USD1,000,000USD3,999,000USD359,000USD212,000USD
    Net Income Applicable To Common Shares——-267,000,000USD52,830,000USD-84,710,000USD-53,082,000USD-17,970,000USD
    Non Operating Income Net Other———397,000USD3,999,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Assets997,000,000USD1,139,000,000USD974,000,000USD1,075,000,000USD1,156,000,000USD1,150,000,000USD1,252,000,000USD1,186,000,000USD
    Other Current Assets15,000,000USD10,000,000USD12,000,000USD15,000,000USD13,000,000USD13,000,000USD17,000,000USD20,000,000USD
    Total Liab473,000,000USD508,000,000USD538,000,000USD526,000,000USD625,000,000USD665,000,000USD687,000,000USD551,000,000USD
    Total Stockholder Equity524,000,000USD631,000,000USD436,000,000USD549,000,000USD531,000,000USD485,000,000USD565,000,000USD635,000,000USD
    Other Current Liab123,000,000USD141,000,000USD128,000,000USD98,000,000USD86,000,000USD110,000,000USD86,000,000USD60,000,000USD
    Common Stock2,138,000,000USD2,116,000,000USD1,815,000,000USD1,793,000,000USD1,775,000,000USD1,617,000,000USD1,602,000,000USD1,582,000,000USD
    Capital Stock2,138,000,000USD2,116,000,000USD1,815,000,000USD1,793,000,000USD1,775,000,000USD1,617,000,000USD1,602,000,000USD1,582,000,000USD
    Retained Earnings-1,613,000,000USD-1,485,000,000USD-1,379,000,000USD-1,244,000,000USD-1,244,000,000USD-1,132,000,000USD-1,038,000,000USD-946,000,000USD
    Cash201,000,000USD222,000,000USD238,000,000USD248,000,000USD192,000,000USD150,000,000USD201,000,000USD156,000,000USD
    Cash And Short Term Investments822,000,000USD981,000,000USD831,000,000USD911,000,000USD997,000,000USD978,000,000USD1,089,000,000USD969,000,000USD
    Total Current Assets844,000,000USD1,007,000,000USD857,000,000USD946,000,000USD1,031,000,000USD1,016,000,000USD1,127,000,000USD1,022,000,000USD
    Total Current Liabilities209,000,000USD231,000,000USD235,000,000USD210,000,000USD192,000,000USD226,000,000USD215,000,000USD199,000,000USD
    Current Deferred Revenue34,000,000USD35,000,000USD52,000,000USD71,000,000USD72,000,000USD85,000,000USD105,000,000USD113,000,000USD
    Net Debt-88,000,000USD-110,000,000USD-127,000,000USD-139,000,000USD-132,000,000USD-90,000,000USD-143,000,000USD-145,000,000USD
    Short Term Debt13,000,000USD13,000,000USD13,000,000USD12,000,000USD12,000,000USD12,000,000USD11,000,000USD11,000,000USD
    Short Long Term Debt Total113,000,000USD112,000,000USD111,000,000USD109,000,000USD60,000,000USD60,000,000USD58,000,000USD11,000,000USD
    Long Term Debt100,000,000USD99,000,000USD98,000,000USD97,000,000USD48,000,000USD48,000,000USD47,000,000USD—
    Long Term Investments54,000,000USD29,000,000USD10,000,000USD16,000,000USD8,000,000USD14,000,000USD2,000,000USD40,000,000USD
    Short Term Investments621,000,000USD759,000,000USD593,000,000USD663,000,000USD805,000,000USD828,000,000USD888,000,000USD813,000,000USD
    Net Receivables7,000,000USD16,000,000USD14,000,000USD20,000,000USD21,000,000USD25,000,000USD21,000,000USD33,000,000USD
    Accounts Payable39,000,000USD42,000,000USD42,000,000USD29,000,000USD22,000,000USD18,000,000USD13,000,000USD15,000,000USD
    Property Plant Equipment Net38,000,000USD40,000,000USD42,000,000USD44,000,000USD46,000,000USD47,000,000USD48,000,000USD49,000,000USD
    Property Plant Equipment Gross38,000,000USD90,000,000USD———88,000,000USD——
    Accumulated Other Comprehensive Income-1,000,000USD—————1,000,000USD-1,000,000USD
    Common Stock Shares Outstanding125,400,000shares107,400,000shares106,500,000shares106,500,000shares98,400,000shares91,700,000shares91,400,000shares91,100,000shares
    Non Current Assets Total153,000,000USD132,000,000USD117,000,000USD129,000,000USD125,000,000USD134,000,000USD125,000,000USD164,000,000USD
    Non Current Liabilities Total264,000,000USD277,000,000USD303,000,000USD316,000,000USD433,000,000USD439,000,000USD472,000,000USD352,000,000USD
    Non Current Liabilities Other119,000,000USD135,000,000USD152,000,000USD159,000,000USD166,000,000USD157,000,000USD136,000,000USD138,000,000USD
    Non Currrent Assets Other61,000,000USD63,000,000USD65,000,000USD69,000,000USD71,000,000USD73,000,000USD75,000,000USD75,000,000USD
    Net Working Capital635,000,000USD776,000,000USD622,000,000USD736,000,000USD839,000,000USD790,000,000USD912,000,000USD823,000,000USD
    Unclassified Non Current Liabilities45,000,000USD43,000,000USD53,000,000USD60,000,000USD219,000,000USD234,000,000USD289,000,000USD214,000,000USD
    Unclassified Equity-2,138,000,000USD-2,116,000,000USD-1,815,000,000USD-1,793,000,000USD-1,775,000,000USD-1,617,000,000USD-1,602,000,000USD-1,582,000,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets1,139,000,000USD1,150,000,000USD1,095,000,000USD1,345,000,000USD1,591,898,000USD772,292,000USD203,110,000USD274,925,000USD
    Other Current Assets10,000,000USD13,000,000USD30,000,000USD14,000,000USD15,620,000USD5,471,000USD4,303,000USD2,321,000USD
    Total Liab508,000,000USD665,000,000USD633,000,000USD688,000,000USD750,448,000USD269,988,000USD39,268,000USD39,983,000USD
    Total Stockholder Equity631,000,000USD485,000,000USD462,000,000USD657,000,000USD841,450,000USD502,304,000USD163,842,000USD234,942,000USD
    Other Current Liab141,000,000USD110,000,000USD65,000,000USD73,000,000USD46,905,000USD28,549,000USD11,002,000USD7,583,000USD
    Common Stock2,116,000,000USD1,617,000,000USD1,311,000,000USD1,206,000,000USD7,000USD6,000USD4,000USD4,000USD
    Capital Stock2,116,000,000USD1,617,000,000USD1,311,000,000USD1,206,000,000USD7,000USD6,000USD4,000USD4,000USD
    Retained Earnings-1,485,000,000USD-1,132,000,000USD-849,000,000USD-542,000,000USD-275,354,000USD-328,184,000USD-205,326,000USD-122,828,000USD
    Cash222,000,000USD150,000,000USD127,000,000USD206,000,000USD147,914,000USD173,415,000USD57,937,000USD71,064,000USD
    Cash And Short Term Investments981,000,000USD978,000,000USD759,000,000USD1,009,000,000USD499,308,000USD728,646,000USD188,270,000USD256,544,000USD
    Total Current Assets1,007,000,000USD1,016,000,000USD831,000,000USD1,066,000,000USD1,261,750,000USD735,815,000USD192,705,000USD258,948,000USD
    Total Current Liabilities231,000,000USD226,000,000USD184,000,000USD193,000,000USD166,084,000USD121,669,000USD22,706,000USD16,935,000USD
    Current Deferred Revenue35,000,000USD85,000,000USD91,000,000USD97,000,000USD102,003,000USD74,571,000USD7,000,000USD6,250,000USD
    Net Debt-110,000,000USD-90,000,000USD-116,000,000USD-86,000,000USD-25,927,000USD-155,305,000USD-57,937,000USD-71,064,000USD
    Short Term Debt13,000,000USD12,000,000USD11,000,000USD3,000,000USD5,100,000USD2,867,000USD9,522,000USD6,023,000USD
    Short Long Term Debt Total112,000,000USD60,000,000USD11,000,000USD120,000,000USD121,987,000USD18,110,000USD——
    Long Term Debt99,000,000USD48,000,000USD——————
    Long Term Investments29,000,000USD14,000,000USD107,000,000USD129,000,000USD181,990,000USD6,440,000USD0USD4,383,000USD
    Short Term Investments759,000,000USD828,000,000USD632,000,000USD803,000,000USD351,394,000USD555,231,000USD130,333,000USD185,480,000USD
    Net Receivables16,000,000USD25,000,000USD42,000,000USD43,000,000USD746,822,000USD1,698,000USD132,000USD83,000USD
    Accounts Payable42,000,000USD18,000,000USD17,000,000USD20,000,000USD10,261,000USD15,682,000USD4,704,000USD3,102,000USD
    Property Plant Equipment Net40,000,000USD47,000,000USD51,000,000USD135,000,000USD137,423,000USD23,588,000USD9,330,000USD11,107,000USD
    Property Plant Equipment Gross90,000,000USD88,000,000USD82,000,000USD58,000,000USD155,151,000USD10,807,000USD9,330,000USD11,107,000USD
    Common Stock Shares Outstanding107,400,000shares90,100,000shares74,000,000shares72,000,000shares73,966,267shares54,787,118shares43,825,991shares34,618,237shares
    Non Current Assets Total132,000,000USD134,000,000USD264,000,000USD279,000,000USD330,147,999USD36,476,999USD10,405,000USD15,977,000USD
    Non Current Liabilities Total277,000,000USD439,000,000USD449,000,000USD495,000,000USD584,364,000USD148,319,000USD16,562,000USD23,048,000USD
    Non Current Liabilities Other135,000,000USD157,000,000USD142,000,000USD140,000,000USD584,364,000USD148,319,000USD806,000USD1,792,000USD
    Non Currrent Assets Other63,000,000USD73,000,000USD106,000,000USD10,000,000USD7,729,999USD6,245,999USD1,075,000USD487,000USD
    Net Working Capital776,000,000USD790,000,000USD647,000,000USD874,000,000USD1,095,666,000USD614,146,000USD169,999,000USD242,013,000USD
    Unclassified Non Current Liabilities43,000,000USD234,000,000USD307,000,000USD-26,000,000USD-471,477,000USD-136,276,000USD-16,562,000USD-23,048,000USD
    Unclassified Equity-2,116,000,000USD-1,617,000,000USD-1,311,000,000USD-1,206,000,000USD1,118,051,000USD830,432,000USD369,096,000USD357,869,000USD
    Deferred Long Term Liab———3,000,000USD4,000,000USD3,200,000USD15,756,000USD21,256,000USD
    Other Liab———378,000,000USD467,477,000USD133,076,000USD16,562,000USD23,048,000USD
    Other Assets———14,000,000USD10,735,000USD25,670,000USD1,075,000USD487,000USD
    Inventory———-172,000,000USD-762,442,000USD-7,169,000USD——
    Accumulated Other Comprehensive Income———-7,000,000USD-1,261,000USD44,000USD64,000USD-107,000USD
    Net Tangible Assets———657,000,000USD841,450,000USD502,304,000USD163,842,000USD234,942,000USD
    Unclassified Non Current Assets———-9,000,000USD-7,730,000USD-25,467,000USD-1,075,000USD—
    Unclassified Current Liabilities————1,815,000USD—-9,522,000USD-6,023,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USDQ1 20242024-03-31 · USD
    Net Income-128,000,000USD-106,000,000USD-135,000,000USD-112,000,000USD-94,000,000USD-92,000,000USD-93,000,000USD-4,000,000USD
    Depreciation2,000,000USD3,000,000USD2,000,000USD3,000,000USD3,000,000USD2,000,000USD2,000,000USD3,000,000USD
    Stock Based Compensation19,000,000USD15,000,000USD14,000,000USD16,000,000USD17,000,000USD19,000,000USD20,000,000USD20,000,000USD
    Other Non Cash Items19,000,000USD-2,000,000USD1,000,000USD-2,000,000USD-3,000,000USD-4,000,000USD-4,000,000USD16,000,000USD
    Change To Account Receivables8,000,000USD5,000,000USD4,000,000USD5,000,000USD-4,000,000USD12,000,000USD7,000,000USD13,000,000USD
    Change In Working Capital-31,000,000USD-30,000,000USD21,000,000USD-37,000,000USD-23,000,000USD101,000,000USD-19,000,000USD-37,000,000USD
    Total Cash From Operating Activities-138,000,000USD-120,000,000USD-97,000,000USD-132,000,000USD-100,000,000USD26,000,000USD-94,000,000USD-2,000,000USD
    Capital Expenditures0USD-1,000,000USD0USD-1,000,000USD-1,000,000USD-1,000,000USD0USD-4,000,000USD
    Free Cash Flow-138,000,000USD-121,000,000USD-97,000,000USD-133,000,000USD-101,000,000USD25,000,000USD-94,000,000USD-6,000,000USD
    Investments114,000,000USD-181,000,000USD79,000,000USD32,000,000USD51,000,000USD-29,000,000USD63,000,000USD-169,000,000USD
    Total Cashflows From Investing Activities114,000,000USD-182,000,000USD79,000,000USD32,000,000USD51,000,000USD-29,000,000USD63,000,000USD-169,000,000USD
    Total Cash From Financing Activities3,000,000USD286,000,000USD8,000,000USD142,000,000USD-2,000,000USD48,000,000USD2,000,000USD229,000,000USD
    Issuance Of Capital Stock0USD279,000,000USD8,000,000USD142,000,000USD0USD0USD0USD228,000,000USD
    Change In Cash-21,000,000USD-16,000,000USD-10,000,000USD42,000,000USD-51,000,000USD45,000,000USD-29,000,000USD58,000,000USD
    Begin Period Cash Flow225,000,000USD241,000,000USD251,000,000USD153,000,000USD204,000,000USD159,000,000USD185,000,000USD130,000,000USD
    End Period Cash Flow204,000,000USD225,000,000USD241,000,000USD195,000,000USD153,000,000USD204,000,000USD156,000,000USD188,000,000USD
    Other Cashflows From Financing Activities3,000,000USD286,000,000USD8,000,000USD—-2,000,000USD1,000,000USD-1,000,000USD1,000,000USD
    Unclassified Operating Cash Flow-19,000,000USD———————
    Net Borrowings—0USD0USD—0USD47,000,000USD——
    Unclassified Financing Cash Flow—-279,000,000USD-8,000,000USD———4,000,000USD—
    Sale Purchase Of Stock—————1,000,000USD-1,000,000USD—
    Other Cashflows From Investing Activities——————63,000,000USD-165,000,000USD
    Unclassified Investing Cash Flow——————-63,000,000USD169,000,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USD
    Net Income-353,000,000USD-283,000,000USD-307,000,000USD-267,000,000USD52,830,000USD-122,858,000USD-49,594,000USD-53,082,000USD
    Depreciation10,000,000USD10,000,000USD8,000,000USD14,000,000USD3,843,000USD4,191,000USD3,664,000USD2,612,000USD
    Stock Based Compensation60,000,000USD76,000,000USD73,000,000USD65,000,000USD55,000,000USD22,000,000USD3,874,000USD495,000USD
    Other Non Cash Items-5,000,000USD5,000,000USD-9,000,000USD68,000,000USD3,474,000USD-46,000USD-177,000USD-98,000USD
    Change To Account Receivables9,000,000USD28,000,000USD15,000,000USD704,000,000USD-17,046,000USD-917,000USD-58,000USD380,000USD
    Change In Working Capital-194,000,000USD22,000,000USD-71,000,000USD623,000,000USD-375,618,000USD208,058,000USD1,332,000USD24,598,000USD
    Total Cash From Operating Activities-482,000,000USD-170,000,000USD-306,000,000USD438,000,000USD-256,171,000USD111,170,000USD-42,996,000USD-25,059,000USD
    Capital Expenditures-2,000,000USD-6,000,000USD-24,000,000USD-6,000,000USD-26,078,000USD-3,055,000USD-3,743,000USD-5,514,000USD
    Free Cash Flow-484,000,000USD-176,000,000USD-330,000,000USD432,000,000USD-282,249,000USD108,115,000USD-46,739,000USD-30,573,000USD
    Investments68,000,000USD-84,000,000USD213,000,000USD-413,000,000USD-28,791,000USD-431,312,000USD-109,697,000USD-43,557,000USD
    Total Cashflows From Investing Activities66,000,000USD-84,000,000USD194,000,000USD-413,000,000USD-3,868,000USD-434,367,000USD-113,440,000USD-49,071,000USD
    Net Borrowings49,000,000USD47,000,000USD0USD0USD————
    Total Cash From Financing Activities488,000,000USD277,000,000USD33,000,000USD33,000,000USD237,340,000USD438,675,000USD129,074,000USD107,396,000USD
    Issuance Of Capital Stock429,000,000USD228,000,000USD36,000,000USD23,000,000USD220,235,000USD433,776,000USD125,111,000USD—
    Change In Cash72,000,000USD23,000,000USD-79,000,000USD58,086,000USD-22,699,000USD115,478,000USD-27,362,000USD33,266,000USD
    Begin Period Cash Flow153,000,000USD130,000,000USD209,000,000USD147,914,000USD173,618,000USD58,140,000USD98,426,000USD65,160,000USD
    End Period Cash Flow225,000,000USD153,000,000USD130,000,000USD206,000,000USD150,919,000USD173,618,000USD71,064,000USD98,426,000USD
    Other Cashflows From Financing Activities488,000,000USD2,000,000USD8,000,000USD33,000,000USD12,340,000USD4,675,000USD3,963,000USD107,396,000USD
    Unclassified Financing Cash Flow-478,000,000USD—-11,000,000USD—230,006,000USD434,054,000USD—-107,769,000USD
    Unclassified Investing Cash Flow—6,000,000USD5,000,000USD9,000,000USD29,001,000USD431,000,000USD109,697,000USD43,557,000USD
    Change To Inventory——-15,000,000USD-704,000,000USD14,085,000USD21,324,000USD——
    Change To Liabilities———-104,000,000USD4,867,000USD24,066,000USD3,118,000USD23,320,000USD
    Sale Purchase Of Stock———0USD-6,000USD-54,000USD124,976,000USD107,769,000USD
    Other Cashflows From Investing Activities———-3,000,000USD22,000,000USD-431,000,000USD-109,697,000USD-43,557,000USD
    Unclassified Operating Cash Flow———-65,000,000USD4,300,000USD—-2,095,000USD—
    Dividends Paid————-5,000,000USD———
    Cash And Cash Equivalents Changes————-22,699,000USD115,478,000USD-27,362,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2025Quarterly · 2025-03-31ProductLicense0USD0001724521-26-000034
    Q1 2025Quarterly · 2025-03-31ProductLicense And Development Services20,000,000USD0001724521-26-000034
    Q1 2025Quarterly · 2025-03-31ProductOther Collaboration Revenue — Access Rights6,000,000USD0001724521-26-000034
    Q1 2025Quarterly · 2025-03-31ProductOther Collaboration Revenue — RDServices2,000,000USD0001724521-26-000034
    Q1 2025Quarterly · 2025-03-31ProductOther Services0USD0001724521-26-000034
    FY 2024Yearly · 2024-12-31ProductLicense And RDServices207,000,000USD0001724521-25-000040
    FY 2024Yearly · 2024-12-31ProductLicense Revenue15,000,000USD0001724521-25-000040
    FY 2024Yearly · 2024-12-31ProductOther Collaboration Revenue — Access Rights28,000,000USD0001724521-25-000040
    FY 2024Yearly · 2024-12-31ProductOther Collaboration Revenue — RDServices8,000,000USD0001724521-25-000040
    FY 2024Yearly · 2024-12-31ProductOther Services0USD0001724521-25-000040
    Q1 2024Quarterly · 2024-03-31ProductLicense And RDServices131,000,000USD0001724521-25-000063
    Q1 2024Quarterly · 2024-03-31ProductOther Collaboration Revenue — Access Rights8,000,000USD0001724521-25-000063
    Q1 2024Quarterly · 2024-03-31ProductOther Collaboration Revenue — RDServices2,000,000USD0001724521-25-000063
    Q1 2024Quarterly · 2024-03-31ProductOther Services4,000,000USD0001724521-25-000063
    Q2 2022Quarterly · 2022-06-30ProductLicense And Development Services Revenue16,693,000USD0000950170-22-014280
    Q2 2022Quarterly · 2022-06-30ProductLicense And Service — Other Collaboration Revenue10,066,000USD0000950170-22-014280
    Q1 2022Quarterly · 2022-03-31ProductLicense And Development Services Revenue7,939,000USD0000950170-22-008502
    Q1 2022Quarterly · 2022-03-31ProductLicense And Service — Other Collaboration Revenue10,066,000USD0000950170-22-008502
    FY 2021Yearly · 2021-12-31ProductGilead Collaboration Access Rights31,000,000USD0001724521-24-000052
    FY 2021Yearly · 2021-12-31ProductGilead Collaboration License And RDServices1,000,000USD0001724521-24-000052
    FY 2021Yearly · 2021-12-31ProductGilead Collaboration License To Domvanalimab329,000,000USD0001724521-24-000052
    FY 2021Yearly · 2021-12-31ProductTaiho Collaboration Access Rights7,000,000USD0001724521-24-000052
    FY 2021Yearly · 2021-12-31ProductTaiho Collaboration License To Domvanalimab15,000,000USD0001724521-24-000052
    FY 2021Yearly · 2021-12-31ProductTaiho Collaboration RDServices0USD0001724521-24-000052
    Q3 2021Quarterly · 2021-09-30ProductOther Collaboration Revenue — Gilead Access Rights7,711,000USD0000950170-22-021241
    Q3 2021Quarterly · 2021-09-30ProductOther Collaboration Revenue — Taiho Access Rights1,750,000USD0000950170-22-021241
    Q2 2021Quarterly · 2021-06-30ProductOther Collaboration Revenue — Gilead Access Rights7,711,000USD0000950170-22-014280
    Q2 2021Quarterly · 2021-06-30ProductOther Collaboration Revenue — Taiho Access Rights1,750,000USD0000950170-22-014280
    Q1 2021Quarterly · 2021-03-31ProductOther Collaboration Revenue — Gilead Access Rights7,711,000USD0000950170-22-008502
    Q1 2021Quarterly · 2021-03-31ProductOther Collaboration Revenue — Taiho Access Rights1,750,000USD0000950170-22-008502
    FY 2020Yearly · 2020-12-31ProductLicense55,096,000USD0000950170-22-001788
    FY 2020Yearly · 2020-12-31ProductLicense And Service — Other Collaboration Revenue22,421,000USD0000950170-22-001788
    Q3 2020Quarterly · 2020-09-30ProductGilead Access Rights7,684,000USD0001564590-20-051355
    Q3 2020Quarterly · 2020-09-30ProductGilead License To Zimberelimab55,096,000USD0001564590-20-051355
    Q3 2020Quarterly · 2020-09-30ProductTaiho Collaboration Agreement1,750,000USD0001564590-20-051355
    FY 2019Yearly · 2019-12-31ProductLicense8,000,000USD0000950170-22-001788
    FY 2019Yearly · 2019-12-31ProductLicense And Service — Other Collaboration Revenue7,000,000USD0000950170-22-001788
    FY 2018Yearly · 2018-12-31ProductLicense3,000,000USD0001564590-21-008270
    FY 2018Yearly · 2018-12-31ProductLicense And Service — Collaboration5,353,000USD0001564590-21-008270

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.